Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action (Q40128025)

17 September 2017

Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action (English)

1 reference

17 September 2017

1 reference

Hong Jiang

1

1 reference

17 September 2017

David J Polhemus

2

1 reference

17 September 2017

Kazi N Islam

3

1 reference

17 September 2017

Ashley C Torregrossa

4

1 reference

17 September 2017

Zhen Li

5

1 reference

17 September 2017

Amy Potts

6

1 reference

17 September 2017

David J Lefer

7

1 reference

17 September 2017

Nathan S Bryan

8

1 reference

17 September 2017

8 January 2016

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

17 September 2017

1 reference

17 September 2017

21

1 reference

17 September 2017

5

1 reference

17 September 2017

478-485

1 reference

Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.

17 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

The beta-adrenergic receptor in pulmonary arterial hypertension: a novel therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nitric oxide mediated venodilator effects of nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nitrosylation. the prototypic redox-based signaling mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

S-Nitrosothiols: cellular formation and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

A Novel Reaction Mechanism for the Formation ofS-Nitrosothiolin Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Protection from experimental asthma by an endogenous bronchodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Measurement of nitric oxide levels in the red cell: validation of tri-iodide-based chemiluminescence with acid-sulfanilamide pretreatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Nebivolol: the somewhat-different beta-adrenergic receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

S-nitrosoprotein formation and localization in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

Methods to detect nitric oxide and its metabolites in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248415626300

21 January 2018

Identifiers

DOI

10.1177/1074248415626300

1 reference

17 September 2017

1 reference